The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

MLA

van Tilborg Theodora C, et al. “The OPTIMIST Study: Optimisation of Cost Effectiveness through Individualised FSH Stimulation Dosages for IVF Treatment. A Randomised Controlled Trial.” BMC Women’s Health, vol. 12, no. 1, Sept. 2012, p. 29. EBSCOhost, https://doi.org/10.1186/1472-6874-12-29.

APA

van Tilborg Theodora C, Eijkemans Marinus JC, Laven Joop SE, Koks Carolien AM, de Bruin Jan, Scheffer Gabrielle J, van Golde Ron JT, Fleischer Kathrin, Hoek Annemieke, Nap Annemiek W, Kuchenbecker Walter KH, Manger Petra A, Brinkhuis Egbert A, van Heusden Arne M, Sluijmer Alexander V, Verhoeff Arie, van Hooff Marcel HA, Friederich Jaap, Smeenk Jesper MJ, … Broekmans Frank JM. (2012). The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Women’s Health, 12(1), 29. https://doi.org/10.1186/1472-6874-12-29

Chicago

van Tilborg Theodora C, Eijkemans Marinus JC, Laven Joop SE, Koks Carolien AM, de Bruin Jan, Scheffer Gabrielle J, van Golde Ron JT, et al. 2012. “The OPTIMIST Study: Optimisation of Cost Effectiveness through Individualised FSH Stimulation Dosages for IVF Treatment. A Randomised Controlled Trial.” BMC Women’s Health 12 (1): 29. doi:10.1186/1472-6874-12-29.